A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers
S1815 is permanently closed to accrual effective February 15, 2021, at 11:59pm Pacific.
